Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arun Pandian Chandrasekaran

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cell Stem Cell|February 2, 2024
Extra (embryonic) dialogues: Keys to improved stem cell-based embryo modelsArun Pandian Chandrasekaran, Mo Li
Cellular and Molecular Life Sciences : CMLS|April 14, 2017
Genome editing: a robust technology for human stem cellsArun Pandian Chandrasekaran, Minjung Song, Suresh Ramakrishna
Current Protocols|September 20, 2023
Quantification of Genetic Heterogeneity Using Long-Read Targeted Individual DNA Molecule SequencingYingzi Zhang, Arun Pandian Chandrasekaran, Chongwei Bi, et al.
BMB Reports|February 15, 2019
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?Naresh Poondla, Arun Pandian Chandrasekaran, Kye-Seong Kim, et al.
Progress in Molecular Biology and Translational Science|October 21, 2018
Different Methods of Delivering CRISPR/Cas9 Into CellsArun Pandian Chandrasekaran, Minjung Song, Kye-Seong Kim, et al.
Biotechnology Journal|February 14, 2022
The role of the CRISPR-Cas system in cancer drug development: Mechanisms of action and therapyArun Pandian Chandrasekaran, Janardhan Keshav Karapurkar, Hee Yong Chung, et al.
Biochemical and Biophysical Research Communications|March 14, 2019
CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosisNaresh Poondla, Arun Pandian Chandrasekaran, Klaus Heese, et al.
Theranostics|November 24, 2021
USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2Arun Pandian Chandrasekaran, Kamini Kaushal, Chang-Hwan Park, et al.
Stem Cells (Dayton, Ohio)|June 25, 2016
Concise Review: Fate Determination of Stem Cells by Deubiquitinating EnzymesArun Pandian Chandrasekaran, Bharathi Suresh, Hyongbum Henry Kim, et al.
Oncology Letters|September 1, 2020
YM155 sensitizes HeLa cells to TRAIL-mediated apoptosis via cFLIP and survivin downregulationArun Pandian Chandrasekaran, Naresh Poondla, Na Re Ko, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cell Stem Cell|February 2, 2024
Extra (embryonic) dialogues: Keys to improved stem cell-based embryo modelsArun Pandian Chandrasekaran, Mo Li
Cellular and Molecular Life Sciences : CMLS|April 14, 2017
Genome editing: a robust technology for human stem cellsArun Pandian Chandrasekaran, Minjung Song, Suresh Ramakrishna
Current Protocols|September 20, 2023
Quantification of Genetic Heterogeneity Using Long-Read Targeted Individual DNA Molecule SequencingYingzi Zhang, Arun Pandian Chandrasekaran, Chongwei Bi, et al.
BMB Reports|February 15, 2019
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?Naresh Poondla, Arun Pandian Chandrasekaran, Kye-Seong Kim, et al.
Progress in Molecular Biology and Translational Science|October 21, 2018
Different Methods of Delivering CRISPR/Cas9 Into CellsArun Pandian Chandrasekaran, Minjung Song, Kye-Seong Kim, et al.
Biotechnology Journal|February 14, 2022
The role of the CRISPR-Cas system in cancer drug development: Mechanisms of action and therapyArun Pandian Chandrasekaran, Janardhan Keshav Karapurkar, Hee Yong Chung, et al.
Biochemical and Biophysical Research Communications|March 14, 2019
CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosisNaresh Poondla, Arun Pandian Chandrasekaran, Klaus Heese, et al.
Theranostics|November 24, 2021
USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2Arun Pandian Chandrasekaran, Kamini Kaushal, Chang-Hwan Park, et al.
Stem Cells (Dayton, Ohio)|June 25, 2016
Concise Review: Fate Determination of Stem Cells by Deubiquitinating EnzymesArun Pandian Chandrasekaran, Bharathi Suresh, Hyongbum Henry Kim, et al.
Oncology Letters|September 1, 2020
YM155 sensitizes HeLa cells to TRAIL-mediated apoptosis via cFLIP and survivin downregulationArun Pandian Chandrasekaran, Naresh Poondla, Na Re Ko, et al.
Pageof 3